Legal Team Pursues Class Action on Mergers Involving CRGX, HSON, BRZH, and ENZB

M&A Class Action Firm Investigates Major Mergers

In a significant move for shareholders, Juan Monteverde, a prominent Class Action Attorney at Monteverde & Associates PC, has initiated a legal inquiry regarding several high-profile mergers. The firm, which has garnered recognition as one of the top 50 in its field in the 2024 ISS Securities Class Action Services Report, is based in the iconic Empire State Building in New York City.

Monteverde & Associates PC has a long-standing track record of recovering millions for investors. As part of its current investigation, the firm is delving into the merger involving CARGO Therapeutics, Inc. (NASDAQ: CRGX). The pharmaceutical company is anticipated to be acquired by Concentra Biosciences, LLC, with shareholders set to receive $4.379 in cash for each CARGO share owned. Additionally, shareholders will obtain a contingent value right, granting them potential financial returns based on future sales of various therapies developed by CARGO, contingent on net cash reserves exceeding $217.5 million at the time of closure.

Furthermore, the legal firm is investigating Hudson Global, Inc. (HSON), which is merging with Star Equity Holdings, Inc. This consolidation means that Hudson shareholders will collectively own about 79% of the newly formed entity post-merger. With a shareholder vote set to occur on August 21, 2025, shareholders are urged to stay informed about the implications of this transaction.

Additionally, Monteverde & Associates is analyzing the merger of Breeze Holdings Acquisition Corp. (OTC: BRZH) with YD Biopharma Limited. Per the agreement, current shareholders of Breeze Holdings will have their shares exchanged for those of the surviving company. The critical shareholder vote for this transaction is scheduled for August 14, 2025.

Moreover, the legal team is scrutinizing Enzo Biochem, Inc. (OTCMKTS: ENZB), which is set to be acquired by Battery Ventures, offering shareholders $0.70 per share. A shareholder vote on this deal is also planned for August 19, 2025.

Monteverde & Associates is committed to providing comprehensive support to shareholders during these complex transactions. The firm emphasizes that it is vital for investors to thoroughly vet law firms before choosing representation. Potential clients should inquire about the firm’s experience with class actions, success in recovering funds for shareholders, and specific cases previously handled.

This proactive approach reflects Monteverde & Associates’ dedication to holding corporations accountable and ensuring that every shareholder is informed and protected.

In closing, shareholders of the aforementioned companies are encouraged to visit Monteverde & Associates’ website or to reach out directly for additional, obligation-free information. The firm’s ethos revolves around ensuring that no company, director, or officer is immune to lawful accountability.

For inquiries related to your rights as a shareholder in these matters, or if you require further information, contact Juan Monteverde at Monteverde & Associates PC. He is available via email or phone, ready to assist shareholders navigating these impactful mergers.

Contact Details

Juan Monteverde, Esq.
Monteverde & Associates PC
Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
Email: [email protected]
Phone: (212) 971-1341

Attorney advertising practices apply, and previous results do not ensure similar outcomes in future matters.